ArticleInternational journal of general medicine2026
Efficacy of Intestinal Obstruction Catheter Combined with Modified Dachengqi Decoction in Elderly Patients with Early Postoperative Inflammatory Intestinal Obstruction: A Randomised Study.
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comments on Randomized Trial of Intestinal Obstruction Catheter Combined with Modified Dachengqi Decoction [Letter].International journal of general medicine · 2026Article
- Bridging Traditions: Integrating TCM Into ERAS for Enhanced Gastrointestinal Recovery -A Scoping Review.Drug design, development and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to evaluate the efficacy of a combined therapy integrating a nasointestinal decompression catheter with a modified Dachengqi Decoction (mDQD) for elderly patients diagnosed with early postoperative inflammatory intestinal obstruction (EPIIO) following gastrointestinal emergency surgery. Methods: We conducted a prospective, randomized controlled trial involving 62 elderly EPIIO patients. Participants were randomly assigned to an experimental group (n=31) or a conventional group (n=31). Both groups received standard nasointestinal catheter decompression and conventional Western medical therapy. The experimental group received additional treatment with mDQD administered through the catheter. Outcomes included recovery times (symptom resolution, first flatus, hospital stay), inflammatory markers (white blood cell count, C‑reactive protein, interleukin‑6), and intestinal barrier function (D‑lactate, diamine oxidase), measured before treatment and at 7 and 14 days post‑treatment. Results: The experimental group showed statistically significant improvements in several recovery metrics, including shorter time to symptom resolution, first flatus, and hospital discharge, compared with the conventional group (all P < 0.05). In addition, the experimental group had greater reductions in systemic inflammatory markers and better restoration of intestinal barrier function at days 7 and 14 (P < 0.05). No major adverse events were reported in either group. Conclusion: The combined therapy of an intestinal obstruction catheter and modified Dachengqi Decoction was associated with improved recovery outcomes in elderly patients with early postoperative inflammatory intestinal obstruction, including reduced inflammation and enhanced intestinal barrier function. However, these findings should be interpreted with caution owing to the small sample size and single‑center design. Larger, multicenter randomized trials are needed to confirm the efficacy of this integrated approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.